基质金属蛋白酶及其抑制剂与肿瘤浸润和转移关系的研究
被引量：3
出处
《医学综述》
2002年第10期561-563,共3页
Medical Recapitulate
基金
福州市科委基金项目 (99350 1 0 4 0 0 0 340 )
参考文献12
-
1[1]Douglas B.Invasion and metastasis[J].Cancer and Metastasis Rev,1996,15(1):77.
-
2[2]Matdsian LM.The matrix-de' grading metallopmteinases[J].Biochemistry,1992,14(7):455.
-
3[3]Imai K,Ohuchi E,Aoki T,et al.Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2[J].Cancer Res,1996,56 (12):2707-2710.
-
4[4]Stetler-Stevenson WG,Hewitt R,Corcoran M,et al.Matrix metalloproteinases and tumor invasion:from correlation and causality to the clinic[J].Semin Cancer Biol,1996,7(3):147-154.
-
5[5]Lee E,Vaughan DE,Parikh SH,et al.Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells[J].Circ Res,1996,78(1):44-49.
-
6[6]Khokha R,Waterhouse P,Yagel S,et al.Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells[J].Science,1989,243 (4893):949.
-
7[7]Okada A,Bellocq JP,Rouyer N,et al.Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon,breast,and head and neck carcinomas[J].Proc Natl Acad Sci,1995,92 (7):2730-2734.
-
8[8]Zeng ZS,Guillem JG.Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases[J].Br J Cancer,1995,72 (3):575-582.
-
9[9]Grignon DJ,Sakr W,Toth M,et al.High level of tissue inhibitor of metalloproteinase-2 (TIMP-2)expression associated with poor outcome in invasive bladder cancer[J].Cancer Res,1996,56 (7):1654-1659.
-
10[10]Wang X,Fu X,Brown PD,et al.Matrix metalloproteinase inhibitor BB94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice[J].Cancer Res,1994,54(17):4726.
同被引文献26
-
1饶克勤,陈育德,李连弟.中国前十位恶性肿瘤死亡率的聚集性及其地区分布和相关因素的分析[J].中国卫生统计,1993,10(4):7-13. 被引量：20
-
2Bing-HuiLi PengZhao Shi-ZhengLiu Yue-MingYu MeiHan Jin-KunWen.Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis[J].World Journal of Gastroenterology,2005,11(20):3046-3050. 被引量：21
-
3Ge Lou Ying Gao Xiao-Ming Ning Qi-Fan Zhang.Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor[J].World Journal of Gastroenterology,2005,11(32):5032-5036. 被引量：20
-
4Ze-Yu Wu,Jing-Hua Li,Wen-Hua Zhan,Yu-Long He.Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma[J].World Journal of Gastroenterology,2006,12(18):2941-2944. 被引量：33
-
5John Hiscott,Hakju Kwon,Pierre Genin.A guide for the ECM maze:Methods in Cell-Matrix Adhesion.Clin.Invest,2001,107(2):143-151
-
6Pepper MS.Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.Arterioscler Thromb Vasc Boil,2001,21(7):1104-114
-
7Maruyama S,Kawata R,Shimada T,et al.Study of matrix metalloproteinase 2 and 9 in thyroid papillary cancer.Nippon Jibiinkoka Gakkai Kaiho,2000,103 (5):499-505
-
8Lin SY,Wang YY,Sheu WH,et al.Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.Clin Endocrinol (Oxf),2003,58 (4):513-518
-
9Monig H,Marquardt D,Arendt T,Kloehn S.Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy.Fam Pract.2002,19(5):436-438
-
10Aggarwal BB,Takada Y,Shishodia S,et al.Nuclear transcription factor NF-kappa B:role in biology and medicine.Indian J Exp Biol,2004,42(4):341-353
引证文献3
-
1陈燕昌,陈大良.乳头状甲状腺癌基质金属蛋白酶-9的表达意义[J].肿瘤防治研究,2005,32(1):11-12. 被引量：7
-
2许力,赵中辛,李仁志,徐国祥.NF-kB和MMP-9在甲状腺乳头状癌中的表达及意义[J].安徽卫生职业技术学院学报,2009,8(3):83-85. 被引量：1
-
3陈超伍,马洪升.基质金属蛋白酶在食管癌组织中的表达及与微量元素含量之间的关系[J].世界华人消化杂志,2010,18(19):1995-2000. 被引量：10
二级引证文献18
-
1张慧芹,俞芳,项岫秀,肖红珍,李伟娟,刘秀玲,刘阁玲.Ⅳ型胶原及MMP-9在不同类型甲状腺肿瘤组织中的表达及临床意义[J].北京中医药大学学报,2006,29(7):468-470.
-
2李文荟,郭莉,谭耀文,任肖华,孟慧萍,王晓洁.口腔癌及癌前病变组织中MMP-9基因表达的意义[J].临床口腔医学杂志,2007,23(1):27-28. 被引量：4
-
3张四梅,王玲,孙慧,王宽松.COX-2、MMP-9表达与宫颈癌侵袭转移的关系[J].医学临床研究,2007,24(6):957-959. 被引量：6
-
4胡朝理,靳红义,邱新光,王庆兆,卢秀波.甲状腺髓样癌中NF-κB、MMP-9的表达及其临床意义[J].肿瘤防治研究,2009,36(2):119-122.
-
5孙珂,刘纯.苯丁酸钠对甲状腺滤泡癌细胞侵袭能力及MMP-9和TIMP-1表达的影响[J].中国肿瘤生物治疗杂志,2009,16(1):67-70. 被引量：6
-
6魏志平,马杰,刘彦群.环氧合酶-2反义寡核苷酸对鳞状细胞癌Colo-16细胞基质金属蛋白酶-2表达的影响[J].临床皮肤科杂志,2010,39(3):144-147. 被引量：3
-
7尹伟军,王启广.HIF-1和基质金属蛋白酶-9表达与胃癌侵袭转移的关系[J].中外医学研究,2010,8(18):26-27.
-
8刘剑,王峰,朱利楠,何炜,王留兴,樊青霞.沉默CXCR4基因对食管鳞癌EC-9706细胞中MMP-9基因表达的影响[J].世界华人消化杂志,2011,19(28):2913-2918.
-
9谢林森.食管鳞状细胞癌患者血清中TMM-9和TIMP-1的测定[J].中国实验诊断学,2012,16(11):2093-2094.
-
10黄春珍,王芳,许梦玫,汤琴,刘丽英.丙氨酰谷氨酰胺在食管癌术后的应用与护理[J].世界华人消化杂志,2013,21(26):2698-2701. 被引量：4
-
1林峰.基质金属蛋白酶及其抑制剂与大肠癌肝转移的研究进展[J].肿瘤学杂志,2002,8(3):174-176. 被引量：4
-
2王剑火,施作霖,陈梓甫.基质金属蛋白酶及其抑制剂与几种常见的泌尿系肿瘤[J].临床与实验病理学杂志,2000,16(3):247-248. 被引量：3
-
3王岩,刘晓霞,侯正文,柳春晖,马秀萍,陈丽萍,贾支红,方虹.基质金属蛋白酶及其抑制剂在乳腺癌转移、浸润中的作用[J].临床与实验病理学杂志,2002,18(3):273-275. 被引量：12
-
4吴登龙.基质金属蛋白酶及其抑制剂与泌尿系肿瘤的浸润与转移[J].国外医学（泌尿系统分册）,1998,18(1):30-33. 被引量：10
-
5许璟,刘伟国.基质金属蛋白酶及其抑制剂与脑肿瘤侵袭转移的关系[J].浙江创伤外科,2002,7(2):138-140.
-
6刘嵘,丁华野.基质金属蛋白酶及其抑制剂与乳腺癌的浸润与转移[J].诊断病理学杂志,2000,7(4):298-300. 被引量：3
-
7刘辉,吕丽琼,莫小勤,成名,杨杰.MMP-2、MMP-7、MMP-9、TIMP-1及TIMP-2在乳腺癌组织中的表达及意义[J].现代生物医学进展,2015,15(16):3046-3048. 被引量：17
-
8高峰,刘思源,胡彤宇,王晓梅,赵玉峰.基质金属蛋白酶及其抑制剂在软骨肉瘤中的表达及临床意义[J].中华实验外科杂志,2011,28(4):614-614. 被引量：1
-
9刘涛(综述),谢民强(审校).基质金属蛋白酶及其抑制剂与鼻咽癌的浸润和转移[J].国际肿瘤学杂志,2008,35(10):762-764.
-
10蔡凤林,周士福.基质金属蛋白酶及其抑制剂在乳腺癌中的研究进展[J].医学综述,2007,13(14):1073-1075.
